Deregulated immune cell recruitment orchestrated by c-MET impairs pulmonary inflammation and fibrosis

Deregulated immune cell recruitment orchestrated by c-MET impairs pulmonary inflammation and fibrosis

Abstract Background Pulmonary fibrosis (PF) represents the pathologic end stage of several interstitial lung diseases (ILDs) associated with high morbidity and mortality rates. However, current treatments can only delay disease progression rather than provide a cure. The role of inflammation in PF p...

Full description

Bibliographic Details
Main Authors: Catarina Barbosa-Matos, Caroline Borges-Pereira, Sofia Libório-Ramos, Raquel Fernandes, Marcela Oliveira, Ana Mendes-Frias, Ricardo Silvestre, Nuno S. Osório, Hélder N. Bastos, Rita F. Santos, Susana Guimarães, António Morais, Massimiliano Mazzone, Agostinho Carvalho, Cristina Cunha, Sandra Costa
Format: Article
Language:English
Published: BMC 2024-06-01
Series:Respiratory Research
Subjects:
Bleomycin
c-MET
ILDs
Inflammation
Pulmonary fibrosis
Online Access:https://doi.org/10.1186/s12931-024-02884-1

Internet

https://doi.org/10.1186/s12931-024-02884-1

Similar Items